Lake Street upgraded Sight Sciences (SGHT) to Buy from Hold with a price target of $5, up from $3, following the company’s Q2 report. Stabilizing Surgical Glaucoma, “prudent” guidance, gross margins that were “not as bad as feared,” dry eye upside, and a “cheap valuation” are also cited by the analyst as reasons for the upgrade.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SGHT: